Patents by Inventor Robert Sklar

Robert Sklar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating muscle diseases and disorders
    Patent number: 8026213
    Abstract: The invention relates to methods of treating diseases and disorders of the muscle tissues in a vertebrate by the administration of compounds which bind the p185erbB2 receptor. These compounds are found to cause increased differentiation and survival of cardiac, skeletal and smooth muscle.
    Type: Grant
    Filed: May 17, 2010
    Date of Patent: September 27, 2011
    Assignee: Acorda Therapeutics, Inc.
    Inventors: Robert Sklar, Mark Marchionni, David I. Gwynne
  • METHODS FOR TREATING MUSCLE DISEASES AND DISORDERS
    Publication number: 20110144015
    Abstract: The invention relates to methods of treating diseases and disorders of the muscle tissues in a vertebrate by the administration of compounds which bind the p185erbB2 receptor. These compounds are found to cause increased differentiation and survival of cardiac, skeletal and smooth muscle.
    Type: Application
    Filed: May 17, 2010
    Publication date: June 16, 2011
    Inventors: Robert Sklar, Mark Marchionni, David I Gwynne
  • Methods for treating muscle diseases and disorders
    Patent number: 7718606
    Abstract: The invention relates to methods of treating diseases and disorders of the muscle tissues in a vertebrate by the administration of compounds which bind the p185erbB2 receptor. These compounds are found to cause increased differentiation and survival of cardiac, skeletal and smooth muscle.
    Type: Grant
    Filed: June 10, 2008
    Date of Patent: May 18, 2010
    Assignee: Acorda Therapeutics, Inc.
    Inventors: Robert Sklar, Mark Marchionni, David I. Gwynne
  • Methods for treating muscle diseases and disorders
    Publication number: 20090018073
    Abstract: The invention relates to methods of treating diseases and disorders of the muscle tissues in a vertebrate by the administration of compounds which bind the p185erbB2 receptor. These compounds are found to cause increased differentiation and survival of cardiac, skeletal and smooth muscle.
    Type: Application
    Filed: June 10, 2008
    Publication date: January 15, 2009
    Applicant: Acorda Therapeutics, Inc.
    Inventors: Robert Sklar, Mark Marchionni, David I. Gwynne
  • Methods for treating muscle diseases and disorders
    Patent number: 7384756
    Abstract: The invention relates to methods of treating diseases and disorders of the muscle tissues in a vertebrate by the administration of compounds which bind the p185erbB2 receptor. These compounds are found to cause increased differentiation and survival of cardiac, skeletal and smooth muscle.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: June 10, 2008
    Assignee: Acorda Therapeutics, Inc.
    Inventors: Robert Sklar, Mark Marchionni, David I. Gwynne
  • Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III
    Patent number: 7115554
    Abstract: The invention relates to methods of treating diseases and disorders of the muscle tissues in a vertebrate by the administration of compounds which bind the p185erbB2 receptor. These compounds are found to cause increased differentiation and survival of cardiac, skeletal and smooth muscle.
    Type: Grant
    Filed: March 8, 1994
    Date of Patent: October 3, 2006
    Assignee: Acorda Therapeutics, Inc.
    Inventors: Robert Sklar, Mark Marchionni, David I. Gwynne
  • Methods for treating muscle diseases and disorders
    Patent number: 7037888
    Abstract: The invention relates to methods of treating diseases and disorders of the muscle tissues in a vertebrate by the administration of compounds which bind the p185erbB2 receptor. These compounds are found to cause increased differentiation and survival of cardiac, skeletal and smooth muscle.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: May 2, 2006
    Assignee: Acorda Therapeutics, Inc.
    Inventors: Robert Sklar, Mark Marchionni, David I. Gwynne
  • Methods of increasing myotube formation or survival or muscle cell mitogenesis, differentiation or survival using a neuregulin
    Patent number: 6444642
    Abstract: The invention relates to methods of treating diseases and disorders of the muscle tissues in a vertebrate by the administration of compounds which bind the p185erbB2 receptor. These compounds are found to cause increased differentiation and survival of cardiac, skeletal and smooth muscle.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: September 3, 2002
    Assignee: CeNes Pharmaceuticals, Inc.
    Inventors: Robert Sklar, Mark Marchionni, David I. Gwynne